FARON PHARMACEUTICALS OY ORD NPV (DI)FARON PHARMACEUTICALS OY ORD NPV (DI)FARON PHARMACEUTICALS OY ORD NPV (DI)

FARON PHARMACEUTICALS OY ORD NPV (DI)

No trades
See on Supercharts
Market capitalization
‪89.03 M‬GBP
‪−26.83 M‬GBP
‪50.02 M‬
Beta (1Y)
0.37

About FARON PHARMACEUTICALS OY ORD NPV (DI)

CEO
Markku Tapani Jalkanen
Headquarters
Turku
Website
Employees (FY)
34
Founded
2003
ISIN
FI4000153309
FIGI
BBG009YWHTF4
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company, which engages in the development of drugs to treat acute respiratory distress syndrome. Its main drug candidates include Traumakine and Bex. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Veikko Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen, and Markku Tapani Jalkanen in 2003 and is headquartered in Turku, Finland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FARN is 129.90 GBX — it has increased by 3.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange FARON PHARMACEUTICALS OY ORD NPV (DI) stocks are traded under the ticker FARN.
FARON PHARMACEUTICALS OY ORD NPV (DI) is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for FARON PHARMACEUTICALS OY ORD NPV (DI) has a max estimate of 4.29 GBX and a min estimate of 1.72 GBX.
FARN earnings for the last quarter are −0.19 GBX whereas the estimation was −0.26 GBX which accounts for 26.67% surprise. Estimated earnings for the next quarter are −0.17 GBX. See more details about FARON PHARMACEUTICALS OY ORD NPV (DI) earnings.
FARON PHARMACEUTICALS OY ORD NPV (DI) revenue for the last quarter amounts to 0 GBX despite the estimated figure of 0 GBX. In the next quarter revenue is expected to reach ‪4.34 K‬ GBX.
Yes, you can track FARON PHARMACEUTICALS OY ORD NPV (DI) financials in yearly and quarterly reports right on TradingView.
Like other stocks, FARN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FARON PHARMACEUTICALS OY ORD NPV (DI) stock right from TradingView charts — choose your broker and connect to your account.
FARN reached its all-time high on Feb 28, 2018 with the price of 889.82 GBX, and its all-time low was 49.99 GBX and was reached on Jun 19, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 34.00 employees. See our rating of the largest employees — is FARON PHARMACEUTICALS OY ORD NPV (DI) on this list?